Trial Profile
A Phase I, Open-Label Drug-Drug Interaction Trial to Investigate the Effect of TMC278 25 mg q.d. on the Steady State Pharmacokinetics of Ethinylestradiol and Norethindrone, in Healthy Women.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 May 2015
Price :
$35
*
At a glance
- Drugs Rilpivirine (Primary) ; Ethinylestradiol/norethisterone
- Indications HIV-1 infections; Pregnancy
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 29 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 29 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Nov 2008 Status changed from recruiting to active, no longer recruiting as reported by Clinicaltrials.gov.